Session 100 - CROI 2010

Home

Session 100-Poster Abstracts
Plasma HIV RNA Monitoring: Suppression and Persistent Viremia
Wednesday, 2-4 pm; Poster Hall

499	Predictors of Attaining <1 Plasma HIV/RNA copies/mL in a Large Italian Cross-sectional Study N Gianotti¹, L Galli¹, S Racca¹, S Salpietro¹, Vincenzo Spagnuolo*¹, B Barda¹, F Canducci¹, M Clementi^1,2, A Lazzarin^1,2, and A Castagna¹ ¹San Raffaele Sci Inst, Milan, Italy and ²Univ Vita-Salute San Raffaele, Milan, Italy
500	Frequency of HIV/RNA Monitoring: Impact on Outcome of ART Romanee Chaiwarith*¹, J Praparattanapan¹, P Salee¹, N Nuntachit¹, W Kotarathititham¹, T Sirisanthana², and K Supparatpinyo^1,2 ¹Faculty of Med, Chiang Mai Univ, Thailand and ²Res Inst for Hlth Sci, Chiang Mai Univ, Thailand
501	HIV-infected Patients with Positive MT-2 Cultures May Need More Frequent Monitoring and/or HAART Initiation at Higher CD4 Counts Angélique van ’t Wout*¹, A van Sighem², M Welkers¹, I Maurer¹, A Harskamp¹, J Prins¹, K Brinkman³, F de Wolf², N Kootstra¹, and H Schuitemaker¹ ¹Academic Med Ctr, Amsterdam, The Netherlands; ²HIV Monitoring Fndn, Amsterdam, The Netherlands; and ³Onze Lieve Vrouwe Gasthius, Amsterdam, The Netherlands
502	Low Level HIV-1 Viremia in Thai Women 24 Weeks after Treatment Initiation with NNRTI-based ART Was Not Associated with Prior Single-dose Nevirapine Exposure or Viral Resistance Mutations Michelle McConnell*¹, T Jariyasethpong², N Chantharojwong¹, C Utenpitak¹, Z Zhou³, J-F Li³, J McNicholl³, O Bolu³, P Weidle³, and T Anekthananon⁴ ¹Thailand Ministry of Publ Hlth-US CDC Collaboration, Nonthaburi; ²Rajavithi Hosp, Ministry of Publ Hlth, Bangkok, Thailand; ³CDC, Atlanta, GA, US; and ⁴Sriraj Hosp, Mahidol Univ, Bangkok, Thailand
503	Episodes of HIV Viremia and the Risk of Non-AIDS Events among Successfully Treated Patients Shuangjie Zhang*¹, A van Sighem¹, L Gras¹, C Smit¹, J Prins², R Kauffmann³, C Richter⁴, P Reiss², F de Wolf^1,4, and the Natl Observational Athena Cohort ¹HIV Monitoring Fndn, Amsterdam, The Netherlands; ²Academic Med Ctr, Univ of Amsterdam, The Netherlands; ³Haga Teaching Hosp, The Hague, The Netherlands; and ⁴Rijnstate Hosp, Arnhem, The Netherlands
504	Persistent Low-level Viremia Is Associated with Increased Risk of Virologic Failure and Mortality Mark Hull*¹, M Loutfy², W Zhang³, A Shen³, E Druyts², M Klein¹, N Machouf⁴, A Rachlis², J Montaner³, R Hogg³, and the Canadian Observational Cohort Collaboration ¹Montreal Chest Inst, McGill Univ Hlth Ctr, Canada; ²Univ of Toronto, Canada; ³BC Ctr for Excellence in HIV/AIDS, Vancouver, Canada; and ⁴Clin Med l’Actuel, Montreal, Canada
505	Association between Low-level Viremia below 50 Copies/mL and Risk of Virologic Rebound in HIV-infected Patients Receiving HAART Anna Maria Geretti*^1,2, T Doyle¹, C Smith², A Garcia^1,2, W Labbett¹, M Johnson^1,2, and A Phillips² ¹Royal Free Hampstead NHS Trust, London, UK and ²Univ Coll London Med Sch, UK
506	Rate of Virologic Decay Explains Immunologic Recovery after ART Vincent Marconi*¹, H Kulkarni², J Okulicz^3,4, G Grandits^3,5, N Crum-Cianflone^3,6, A Ganesan^3,7, M Dolan^3,8, B Agan³, and S Ahuja² ¹Emory Univ Sch of Med, Atlanta, GA, US; ²Univ of Texas Hlth Sci Ctr at San Antonio, US; ³Uniformed Svcs Univ of the Hlth Sci, Bethesda, MD, US; ⁴San Antonio Military Med Ctr, TX, US; ⁵Univ of Minnesota, Minneapolis, US; ⁶Naval Med Ctr San Diego, CA, US; ⁷Natl Naval Med Ctr, Bethesda, MD, US; and ⁸Defense Inst for Med Operations, San Antonio, TX, US